Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Clinical Pediatric Hematology-Oncology ; : 21-36, 2017.
Artículo en Coreano | WPRIM | ID: wpr-788599

RESUMEN

Pediatric renal tumors represent a diverse group, which include Wilms' tumor (WT), renal cell carcinoma (RCC), clear cell sarcoma of the kidney (CCSK), congenital mesoblastic nephroma, malignant rhabdoid tumor of the kidney (MRTK) and primitive neuroectodermal tumor. WT (85%) and RCC (8%) are the most prevalent types. WT predominates among the 1- to 10-year age group, but RCC exceeds WT in children over age 10 years. Pediatric renal tumors are genetically, histologically and clinically heterogeneous. The overall survival for children with localized WT is currently more than 90%, whereas poorer survival rates are observed for anaplastic WT, metastatic WT, metastatic CCSK, MRTK, metastatic RCC and relapsed WT. Therefore risk-stratified treatment is important to minimize treatment morbidity while preserving survival. This review focuses on distinct characteristics of each tumor type and optimal stratified treatment.


Asunto(s)
Niño , Humanos , Carcinoma de Células Renales , Riñón , Nefroma Mesoblástico , Tumores Neuroectodérmicos Primitivos , Tumor Rabdoide , Sarcoma de Células Claras , Tasa de Supervivencia , Tumor de Wilms
2.
Clinical Pediatric Hematology-Oncology ; : 21-36, 2017.
Artículo en Coreano | WPRIM | ID: wpr-197959

RESUMEN

Pediatric renal tumors represent a diverse group, which include Wilms' tumor (WT), renal cell carcinoma (RCC), clear cell sarcoma of the kidney (CCSK), congenital mesoblastic nephroma, malignant rhabdoid tumor of the kidney (MRTK) and primitive neuroectodermal tumor. WT (85%) and RCC (8%) are the most prevalent types. WT predominates among the 1- to 10-year age group, but RCC exceeds WT in children over age 10 years. Pediatric renal tumors are genetically, histologically and clinically heterogeneous. The overall survival for children with localized WT is currently more than 90%, whereas poorer survival rates are observed for anaplastic WT, metastatic WT, metastatic CCSK, MRTK, metastatic RCC and relapsed WT. Therefore risk-stratified treatment is important to minimize treatment morbidity while preserving survival. This review focuses on distinct characteristics of each tumor type and optimal stratified treatment.


Asunto(s)
Niño , Humanos , Carcinoma de Células Renales , Riñón , Nefroma Mesoblástico , Tumores Neuroectodérmicos Primitivos , Tumor Rabdoide , Sarcoma de Células Claras , Tasa de Supervivencia , Tumor de Wilms
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA